<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE PAPER
  SYSTEM "paper-structure-annotation.dtd">
<PAPER><mode2 name="b304943d" hasDoc="yes" version="1153"/><TITLE><s sid="1"><CoreSc1 atype="GSC" type="Obj" conceptID="Obj1" novelty="New" advantage="None"/><text>Caveolin-1 isoform reorganization studied by image correlation spectroscopy</text></s></TITLE><ABSTRACT><s sid="2"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Caveolae are small, flask shaped invaginations in the cell membrane.</text></s> <s sid="3"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>They are thought to play a crucial role in cell signaling, endocytosis and intracellular cholesterol transport.</text></s> <s sid="4"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Caveolin-1, 2 and 3 are key proteins, which are important for the formation of the invaginations on the cell surface.</text></s> <s sid="5"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Caveolin-1 exists in two isoforms: caveolin-1 alpha (α) and caveolin-1 beta (β).</text></s> <s sid="6"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot1" novelty="None" advantage="None"/><text>Little is known about the difference between these two isoforms, and less in known about their role in cell signaling.</text></s> <s sid="7"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>Bone morphogenetic proteins (BMPs) are a subfamily of the TGF beta superfamily and their response is mediated by serine/threonine kinase receptors.</text></s> <s sid="8"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac4" novelty="None" advantage="None"/><text>Epidermal growth factor (EGF) is known to signal through tyrosine kinase receptors of the ErbB family.</text></s> <s sid="9"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><text>Here we report on the aggregation and association of caveolin-1 isoforms with these receptors and the effect of BMP and EGF activation on caveolin-1 distribution in A431 cells.</text></s> <s sid="10"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Our data, obtained by application of a family of image correlation spectroscopy tools, indicate that BMP and EGF stimulation lead to a rearrangement of the caveolin-1 isoforms on the cell surface.</text></s> <s sid="11"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>BMP as well as EGF stimulation leads to a rearrangement of the caveolin-1 β isoform into domains enriched in the caveolin-1 α isoform.</text></s> <s sid="12"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>We further show that about 20–30% of the caveolin-1 present at the surface of the cells co-localize with the EGF and BMP receptors.</text></s> <s sid="13"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>Using a reporter gene assay sensitive to the activation of the BMP pathway, we show that overexpression of caveolin-1 β inhibits signaling.</text></s> <s sid="14"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>Our data suggest that the two isoforms of caveolin-1 play different roles on the cell surface and that caveolae are dynamic structures.</text></s></ABSTRACT><BODY><DIV DEPTH="1"><HEADER>Introduction</HEADER><P><s sid="15"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac1" novelty="None" advantage="None"/><text>Caveolae are small, flask-shaped invaginations of the cell membrane, which are thought to play a crucial role in endocytosis, signaling and intracellular cholesterol transport.<REF TYPE="P" ID="cit1 cit2 cit3">1–3</REF></text></s> <s sid="16"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Caveolin-1, 2 and 3 are the key proteins involved in the formation of the invaginations.<REF TYPE="P" ID="cit4 cit5 cit6">4–6</REF></text></s> <s sid="17"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Caveolin-1 is expressed in two isoforms, caveolin-1 α and caveolin-1 β, that differ in their coding.</text></s> <s sid="18"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>Still, the two caveolin-1 isoforms have a common hydrophobic stretch of amino acids, a scaffolding domain and an acetylated C-terminus.<REF TYPE="P" ID="cit7 cit8">7,8</REF></text></s> <s sid="19"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>They are distributed slightly differently on the cell surface, and previous work suggests that there are caveolae composed only (or mainly) of the β isoform as well as caveolae with both isoforms present.<REF TYPE="P" ID="cit9">9</REF></text></s></P><P><s sid="20"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac6" novelty="None" advantage="None"/><text>Bone morphogenetic proteins (BMPs) play crucial roles during embryonic development in chondrogenesis, osteogenesis, neurogenesis and hematopoiesis.<REF TYPE="P" ID="cit10 cit11 cit12 cit13 cit14 cit15 cit16 cit17">10–17</REF></text></s> <s sid="21"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac3" novelty="None" advantage="None"/><text>They exert their function by signaling through serine threonine kinase receptors.</text></s> <s sid="22"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac7" novelty="None" advantage="None"/><text>BMPs need to bind to at least one type-I and one type-II receptor in order to activate the Smad or p38 pathways.<REF TYPE="P" ID="cit18 cit19 cit20 cit21 cit22 cit23 cit24 cit25 cit26 cit27 cit28">18–28</REF></text></s></P><P><s sid="23"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac8" novelty="None" advantage="None"/><text>Epidermal growth factor (EGF) is in part responsible for the proliferation of cells and exerts its function by signaling through tyrosine kinase receptors, leading to the activation of the Map kinase (Mapk) pathways.<REF TYPE="P" ID="cit29 cit30 cit31">29–31</REF></text></s></P><P><s sid="24"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/><text>There is increasing evidence that domains on the cell surface exist to act as sites for protein–protein interactions leading to activation of specific signaling pathways.</text></s> <s sid="25"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac9" novelty="None" advantage="None"/><text>By serving as regions of the cell surface that can be enriched in receptors to signaling proteins, the probability of interaction among the receptors increases significantly allowing for more rapid responses.</text></s> <s sid="26"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac10" novelty="None" advantage="None"/><text>In the case of the BMP receptors, their organization in caveolae may facilitate creation of preformed complexes of type-I and type II receptors.</text></s> <s sid="27"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac11" novelty="None" advantage="None"/><text>Interactions between receptors and regulatory proteins within the domains can, in principle, lead to either activation or inhibition of the corresponding signaling pathways.</text></s> <s sid="28"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac12" novelty="None" advantage="None"/><text>However, unless the caveolae are specific to particular receptor families, the high density of receptors in the domain could lead to interaction between different receptor systems and hence cross-talk between otherwise distinct signaling pathways.</text></s> <s sid="29"><CoreSc1 atype="GSC" type="Mot" conceptID="Mot2" novelty="None" advantage="None"/><text>It is, therefore, important to study protein–protein interactions within these domains and to determine whether these interactions can change.</text></s></P><P><s sid="30"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa2" novelty="None" advantage="None"/><text>Generally, we aim to understand whether stimulation of a cell with receptor specific ligands influences the receptor distribution or the caveolin composition within the caveolae.</text></s> <s sid="31"><CoreSc1 atype="GSC" type="Goa" conceptID="Goa1" novelty="None" advantage="None"/><text>In this work, we investigate the association of caveolin-1 isoforms with the BMP receptors of type-II (BRII) and type-Ia (BRIa) and with the EGF receptor, ErbB1.</text></s> <s sid="32"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>We apply image correlation spectroscopy techniques to determine quantitatively the density of the receptors and the caveolin-1 isotypes as well as the extent to which they co-localize.</text></s></P></DIV><DIV DEPTH="1"><HEADER>Materials and methods</HEADER><DIV DEPTH="2"><HEADER>Materials</HEADER><P><s sid="33"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp1" novelty="None" advantage="None"/><text>Recombinant BMP-2 was obtained from Wyeth (Boston, NY, USA) and human recombinant EGF was purchased from Sigma (St. Louis, MO, USA).</text></s> <s sid="34"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp2" novelty="None" advantage="None"/><text>The polyclonal antisera against the BMP receptors, BRIa and BRII, and the polyclonal antibody against the EGF receptor were from Santa Cruz (Santa Cruz, CA, USA).</text></s> <s sid="35"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp3" novelty="None" advantage="None"/><text>The antibodies recognizing only caveolin-1 α (clone 2234) or both of the caveolin-1 α and β isoforms (clone 2297) were purchased from Transduction Laboratories (New York, NY, USA).</text></s> <s sid="36"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp4" novelty="None" advantage="None"/><text>The secondary antibodies, donkey anti-goat RRX and goat anti-mouse Alexa Fluor 488, were purchased from Molecular Probes (Eugene, OR, USA).</text></s> <s sid="37"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp5" novelty="None" advantage="None"/><text>The A431 cell line (CRL 1555) was purchased from American Type Culture Collection (Manassa, VA, USA).).</text></s> <s sid="38"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp6" novelty="None" advantage="None"/><text>The plasmid encoding GFP-tagged caveolin-1 β was provided by Dr H. Kogo (Department of Anatomy, Nagoya University School of Medicine, Showa-ku, Nagoya, 466-8550, Japan.)</text></s></P></DIV><DIV DEPTH="2"><HEADER>Immunofluorescence labeling of cell surface receptors</HEADER><P><s sid="39"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>To measure the distribution of the caveolin-1 on the cell surface, we employed ICS and ICCS measurements, which require acquisition of high quality fluorescence images with a laser scanning confocal microscope.</text></s> <s sid="40"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp7" novelty="None" advantage="None"/><text>Normal A431 cells were grown on 22 mm coverslips.</text></s> <s sid="41"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>Following 72 h of serum-starvation, the A431 cells were stimulated, or not stimulated, with 20 nM BMP-2 for 2.5 h or 100 ng mL<SP>−1</SP> EGF for 30 min and fixed using acetone/methanol fixation.<REF TYPE="P" ID="cit32">32</REF></text></s> <s sid="42"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>After blocking for 30 min with 5% BSA, the cells were incubated with polyclonal antisera recognizing either BRII or BRIa, with polyclonal antibody recognizing the EGFR, or with antibodies recognizing caveolin-1 α (clone 2234) or caveolin-1 α and β (clone 2297) according to manufacturers protocols.</text></s> <s sid="43"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp10" novelty="None" advantage="None"/><text>The cells were washed 3 times with PBS for 5 min and afterwards, they were incubated with the corresponding fluorescently tagged secondary antibodies at a concentration of 20 μg mL<SP>−1</SP>.</text></s> <s sid="44"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp11" novelty="None" advantage="None"/><text>Cells were washed again three times for 5 min with PBS and the coverslips were mounted on airvol and dried overnight.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Luciferase reporter assay</HEADER><P><s sid="45"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp12" novelty="None" advantage="None"/><text>A431 cells grown in 60 mm dishes were co-transfected with the plasmid containing a Smad Binding Element (pSBE), which is sensitive to the activation of the BMP signaling pathway, a <IT>Renilla</IT> luciferase reporter construct (which is used for normalization of the chemiluminescence response) and the caveolin-1 β construct using Fugene6 (Boehringer).</text></s> <s sid="46"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp13" novelty="None" advantage="None"/><text>After transfection, the cells were stimulated, or not stimulated, for 12 h with 20 nM BMP-2, lysed and the luciferase activity was measured using a dual luciferase assay system (Promega, Madison, WI, USA).</text></s></P></DIV><DIV DEPTH="2"><HEADER>Confocal microscopy</HEADER><P><s sid="47"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>Labeled cells were visualized using a Biorad MRC 600 confocal microscope equipped with an Ar/Kr mixed gas laser and using the appropriate filter sets for dual fluorophore imaging.</text></s> <s sid="48"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>Cells expressing the receptors were selected under mercury lamp illumination using a 60 × (1.4 numerical aperture) objective on an inverted Nikon microscope.</text></s> <s sid="49"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>An area on the cell, removed from the nucleus, was enlarged and recorded at the zoom 10 setting.</text></s> <s sid="50"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The filter wheel was set for 488 nm laser excitation to measure Alexa Fluor 488 fluorescence, and neutral density filters were used to attenuate the laser to 1% laser power.</text></s> <s sid="51"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>Fifteen scans were accumulated on photomultiplier tube 2 (PMT2) in the photon counting mode (to ensure linear scaling of the intensity).</text></s> <s sid="52"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>The filter wheel was then shifted to allow excitation with the 568 nm laser line for Alexa Fluor 568 fluorescence, and 20 scans were accumulated on PMT1 for BMP receptors, whereas 9 scans were accumulated on PMT1 for the EGF receptor (EFGR).</text></s> <s sid="53"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>Each of the photomultiplier tubes were set to a black level of 6.0 on the vernier scale and a gain setting of 10.</text></s> <s sid="54"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp14" novelty="None" advantage="None"/><text>After collection of each set of images was finished, additional images were collected using identical settings but with the shutter to the sample closed to obtain a measure of the dark current for each PMT.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Correlation spectroscopy</HEADER><P><s sid="55"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>Image correlation spectroscopy (ICS) and image cross-correlation spectroscopy (ICCS) are two techniques that can be used to study the distribution and localization of receptors.<REF TYPE="P" ID="cit33 cit34 cit35 cit36 cit37 cit38">33–38</REF></text></s> <s sid="56"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>The technique and selected applications have been presented previously at Faraday Discussion .111<REF TYPE="P" ID="cit39">39</REF></text></s> <s sid="57"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac13" novelty="None" advantage="None"/><text>Here we provide a brief overview of the techniques and their interpretation.</text></s></P><DIV DEPTH="3"><HEADER>Image correlation spectroscopy</HEADER><P><s sid="58"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>ICS involves autocorrelation analysis of the intensity fluctuations within confocal images collected, in this case, from cells that contain immunofluorescently labeled proteins.</text></s></P><P><s sid="59"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>If the fluorescence intensity in a pixel, located at position (<IT>x</IT>,<IT>y</IT>) in the image, is <IT>i</IT>(<IT>x</IT>,<IT>y</IT>), then the corresponding normalized fluorescence intensity fluctuation, δ<IT>i</IT>(<IT>x</IT>,<IT>y</IT>), is given by: The normalized spatial autocorrelation function, <IT>g</IT>(<IT>ξ</IT>,<IT>η</IT>), is then given by: <IT>g</IT>(<IT>ξ</IT>,<IT>η</IT>) = 〈δ<IT>i</IT>(<IT>x</IT>,<IT>y</IT>)δ<IT>i</IT>(<IT>x</IT> + <IT>ξ</IT>,<IT>y</IT> + <IT>η</IT>)〉where the angular brackets indicate the average over all spatial coordinates and <IT>ξ</IT> and <IT>η</IT> are position lag coordinates for the <IT>x</IT> and <IT>y</IT> axes in the image.</text></s> <s sid="60"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>It is known that the limit of the autocorrelation function as <IT>ξ</IT> and <IT>η</IT> approach zero, <IT>g</IT>(0,0), is equal to the variance of the normalized intensity fluctuations.<REF TYPE="P" ID="cit40">40</REF></text></s> <s sid="61"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod1" novelty="None" advantage="None"/><text>It is also known that for homogenous, non-interacting species, where the intensity is a true representation of the concentration, the variance of the normalized intensity fluctuations is equal to the variance of the concentration fluctuations, which in turn is equal to the inverse of the number of particles in the observation area, <IT>N̄</IT><SB>p</SB>.<REF TYPE="P" ID="cit41">41</REF></text></s></P><P><s sid="62"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>In practice, the two-dimensional autocorrelation function for the image is obtained by first calculating the Fourier transform of the image, then calculating the power spectrum (by multiplying the real and the imaginary components of the transform) and finally calculating the reverse Fourier transform.</text></s> <s sid="63"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod2" novelty="None" advantage="None"/><text>The resulting two-dimensional autocorrelation function is then fit to a two-dimensional gaussian function of known width (corresponding to the width of the laser beam at the focal point of confocal microscope).</text></s> <s sid="64"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod2" novelty="None" advantage="None"/><text>The amplitude of the function obtained from this fit gives the best estimate of <IT>g</IT>(0,0) for that image.</text></s></P><P><s sid="65"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod3" novelty="None" advantage="None"/><text>Once the <IT>g</IT>(0,0) value is known, an important parameter, called the cluster density (CD) can be calculated by eqn. (4).</text></s> <s sid="66"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod3" novelty="None" advantage="None"/><text>The CD value is an estimate of the average number of receptor clusters per unit area <IT>i.e.</IT>, </text></s></P></DIV><DIV DEPTH="3"><HEADER>Image cross correlation spectroscopy</HEADER><P><s sid="67"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac14" novelty="None" advantage="None"/><text>Image cross-correlation spectroscopy (ICCS) is an extension of ICS.</text></s> <s sid="68"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>In ICCS, a cross-correlation function is also generated to measure the coincident fluorescence intensity fluctuations in images collected from two different chromophores attached to two different proteins or receptor types.</text></s> <s sid="69"><CoreSc1 atype="GSC" type="Met" conceptID="Met2" novelty="Old" advantage="None"/><text>One receptor type is labeled with a green probe and is imaged to give the intensity map, <IT>i</IT><SB>g</SB>(<IT>x</IT>,<IT>y</IT>), while the second receptor type is labeled with a red probe and imaged to give the intensity map, <IT>i</IT><SB>r</SB>(<IT>x</IT>,<IT>y</IT>).</text></s> <s sid="70"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod4" novelty="None" advantage="None"/><text>The normalized, spatial cross-correlation function can be calculated as: <IT>g</IT><SB>gr</SB>(<IT>ξ</IT>,<IT>η</IT>) = 〈δ<IT>i</IT><SB>g</SB>(<IT>x</IT>,<IT>y</IT>)δ<IT>i</IT><SB>r</SB>(<IT>x</IT> +<IT>ξ</IT>,<IT>y</IT> + <IT>η</IT>)〉</text></s></P><P><s sid="71"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod4" novelty="None" advantage="None"/><text>In this case, the two-dimensional cross-correlation function is obtained by first calculating the Fourier transform of each of the two images, then cross-multiplying the real part from the green image with the imaginary part from the red image (or the imaginary part from the green image with the real part from the red image, the result is the same) and finally calculating the reverse Fourier transform of the ‘mixed’ power spectrum.</text></s> <s sid="72"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod4" novelty="None" advantage="None"/><text>The resulting cross-correlation function is fit to a two-dimensional gaussian as above to give the amplitude of the cross correlation function, <IT>g</IT><SB>gr</SB>(0,0).</text></s></P><P><s sid="73"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac15" novelty="None" advantage="None"/><text>It has been shown for individual molecules that the zero-lag amplitude of the cross-correlation function reflects the extent of co-localization of the two chromophores on the cell surface.<REF TYPE="P" ID="cit35 cit36">35,36</REF></text></s> <s sid="74"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>We interpret the amplitude to reflect the average number of clusters with both chromophores present.</text></s> <s sid="75"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod5" novelty="None" advantage="None"/><text>Specifically: Here, <IT>N̄</IT><SB>g</SB>, <IT>N̄</IT><SB>r</SB> and <IT>N̄</IT><SB>gr</SB> are the average number of clusters which are made up of only green labeled proteins, only red labeled proteins, and both green and red labeled proteins, respectively.</text></s> <s sid="76"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod5" novelty="None" advantage="None"/><text>Also, <IT>g</IT><SB>g</SB>(0,0) and <IT>g</IT><SB>r</SB>(0,0) are the autocorrelation functions corresponding to the individual green and red images.</text></s> <s sid="77"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>These are calculated from the individual images as indicated above.</text></s></P><P><s sid="78"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod6" novelty="None" advantage="None"/><text>By rearrangement, we can define a cluster density of co-localized chromophores as: The fraction of each protein type associated with the other type can finally be estimated by looking at the appropriate ratios of CD values: In eqn. (8), <IT>F</IT>(g/r) represents the fraction of green labeled protein clusters which contain red labeled proteins.</text></s> <s sid="79"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod6" novelty="None" advantage="None"/><text>Correspondingly, <IT>F</IT>(r/g) is the fraction of red labeled protein clusters containing green labeled proteins.</text></s></P><P><s sid="80"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="Yes"/><text>It can be seen that ICCS provides quantitative information about the extent of co-localization of two different receptors, or in the current work, a receptor and a binding protein.</text></s> <s sid="81"><CoreSc1 atype="GSC" type="Mod" conceptID="Mod5" novelty="None" advantage="None"/><text>The only caveat is that the interpretation of eqn. (6) is strictly only valid for individual chromophores.</text></s></P></DIV></DIV><DIV DEPTH="2"><HEADER>Statistics</HEADER><P><s sid="82"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp15" novelty="None" advantage="None"/><text>The experiments are designed to collect a large number of images, typically forty, each from a different cell in the sample.</text></s> <s sid="83"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac16" novelty="None" advantage="None"/><text>Past work indicates that the largest source of uncertainty in the ICS and ICCS measurements arises from variations between cells in a population.</text></s> <s sid="84"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>In order to obtain a reasonable estimate of the population properties (cluster density, fraction of co-localization) the data are pooled and averaged when more than one experiment is conducted.</text></s> <s sid="85"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>In all cases, the cluster density data are represented relative to the value for one, selected control experiment.</text></s> <s sid="86"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>All the data in a particular experiment are normalized to this same data set.</text></s> <s sid="87"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The values of the standard error of the mean (SEM) were calculated from the raw data at the 95% confidence level.</text></s> <s sid="88"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>The significance of changes relative to the control was assessed by paired, two-tailed <IT>t</IT>-tests.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Results</HEADER><DIV DEPTH="2"><HEADER>Stimulation of A431 cells causes rearrangement of caveolin-1 isoforms</HEADER><P><s sid="89"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp17" novelty="None" advantage="None"/><text>Normally cells are grown in a culture medium to which 10% fetal bovine serum is added.</text></s> <s sid="90"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/><text>The serum provides some nutrients, but most importantly, a series of growth factors that stimulate cell proliferation.</text></s> <s sid="91"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/><text>In the absence of the serum, cells divide less frequently, but grow well for up to one week.</text></s> <s sid="92"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/><text>Removal of the serum, serum starvation, is used to isolate the effect of a specific growth factor on cell signaling, but can also affect the receptor concentration on the cell surface by up- or down-regulation at the gene expression level or through altered turn over through endocytosis.</text></s> <s sid="93"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac17" novelty="None" advantage="None"/><text>Specifically, serum starvation of A431 cells leads to the up-regulation of the BMP-type-II receptor within 72 h as seen by reverse transcription PCR (RT-PCR) and by immunofluorescence.<REF TYPE="P" ID="cit42">42</REF></text></s> <s sid="94"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac18" novelty="None" advantage="None"/><text>Further, starved A431 cells are sensitive to both BMP-2 and EGF stimulation whereas normal A431 cells are less sensitive to BMP-2 stimulation.</text></s></P><P><s sid="95"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>A431 cells were starved for 72 h and then stimulated (or not stimulated in control experiments) with the desired signaling protein.</text></s> <s sid="96"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp8" novelty="None" advantage="None"/><text>The cells were exposed to BMP-2 for 2.5 h or to 100 ng mL<SP>−1</SP> of EGF for 30 min.</text></s> <s sid="97"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>The cells were then fixed and labeled for the caveolin-1 isoforms using a monoclonal antibody against caveolin-1 α or a monoclonal antibody recognizing both α and β isoforms followed by a secondary fluorescent antibody.</text></s> <s sid="98"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs1" novelty="None" advantage="None"/><text>Figs. 1A and 2A show representative confocal images at high magnification (zoom 10 provides 15.5 μm × 15.5 μm images).</text></s> <s sid="99"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>Forty high magnification images of flat regions of the cell surface were collected from forty separate cells and subjected to ICS analysis to provide a cluster density for each image (eqn. (4)).</text></s> <s sid="100"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>The average cluster density was calculated for this large number of images in order to obtain good population statistics.</text></s></P><P><s sid="101"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs2" novelty="None" advantage="None"/><text>Fig. 1B indicates that BMP-2 stimulation of starved A431 cells leads to a 39% decrease in the cluster density of caveolin-1 α and β as detected by labeling with the caveolin-1 antibody clone 2297 (<IT>p</IT> = 8.75 × 10<SP>−5</SP>).</text></s> <s sid="102"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs3" novelty="None" advantage="None"/><text>However, BMP-2 stimulation does not significantly change the cluster density of caveolin-1 α when detected alone by clone 2234 (<IT>p</IT> = 0.97).</text></s> <s sid="103"><CoreSc1 atype="GSC" type="Res" conceptID="Res3" novelty="None" advantage="None"/><text>This suggests that the change in cluster density of caveolin-1 α and β arises from changes in the distribution of the caveolin-1 β isoform.</text></s> <s sid="104"><CoreSc1 atype="GSC" type="Con" conceptID="Con3" novelty="None" advantage="None"/><text>Most likely, BMP-2 stimulation leads to a redistribution of the caveolin-1 β isoform into regions enriched in the α isoform, since the CD of caveolin-1 α and the CD of caveolin-1 α and β are not significantly different following the BMP-2 stimulation (<IT>p</IT> = 0.14).</text></s></P><P><s sid="105"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>Correspondingly, Fig. 2B shows that EGF stimulation leads to a 37% decrease in the cluster density of the caveolin-1 α and β isoform (detected by clone 2297) (<IT>p</IT> = 0.013) and that the stimulation with EGF does not significantly alter the cluster density of the caveolin-1 α isoform (detected by clone 2234) (<IT>p</IT> = 0.96).</text></s> <s sid="106"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs4" novelty="None" advantage="None"/><text>This observation is the same as that observed following BMP-2 stimulation.</text></s> <s sid="107"><CoreSc1 atype="GSC" type="Res" conceptID="Res4" novelty="None" advantage="None"/><text>Thus, EGF stimulation leads to a redistribution of the caveolin-1 β isoform into regions enriched in the caveolin-1 α isoform, since the CD of cavolon-1 α and the CD of caveolin-1 α and β are not significantly changed following EGF stimulation (<IT>p</IT> = 0.84).</text></s> <s sid="108"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Evidently, EGF and BMP-2 cause comparable changes in the caveolin isoform redistribution: in both cases the caveolin-1 β isoform is reorganized into domains enriched in caveolin-1 α following exposure to the signaling protein.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Caveolin-1 isoforms co-localize with BMP and EGF receptors</HEADER><P><s sid="109"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>As described above, stimulation of A431 cells with BMP or EGF influences the aggregation of caveolin-1 β and appears to lead to changes in the composition of the caveolae.</text></s> <s sid="110"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp1" novelty="None" advantage="None"/><text>Since EGF and BMP mediate their signal through receptors that act respectively as serine threonine kinases or tyrosine kinases, it is likely that the influence on the caveolae compositions are caused by direct interactions with the caveolins, rather than through their respective signaling events.</text></s> <s sid="111"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>We, therefore, examined the extent of co-localization of the receptors with each of the caveolin-1 isoforms using image cross-correlation spectroscopy (ICCS).</text></s></P><P><s sid="112"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp9" novelty="None" advantage="None"/><text>Serum starved A431 cells, stimulated or not stimulated with BMP-2 or EGF, were fixed and the BMP receptors, EGF receptors and caveolin-1 isoforms were labeled using the specific antibodies against the proteins of interest and appropriate secondary fluorescent antibodies.</text></s> <s sid="113"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac19" novelty="None" advantage="None"/><text>The BMP and EGF receptors were labeled with donkey anti goat Alexa Fluor 568 conjugated secondary antibodies, whereas the caveolin-1 isoforms were labeled using goat anti mouse Alexa Fluor 488 secondary antibodies.</text></s> <s sid="114"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs5" novelty="None" advantage="None"/><text>Figs. 3A and 4A show representative examples of confocal images of selected, pair-wise labeling of a receptor and a caveolin-1 isoform.</text></s> <s sid="115"><CoreSc1 atype="GSC" type="Res" conceptID="Res5" novelty="None" advantage="None"/><text>It is evident that the extent of co-localization is less than 100% and therefore some of the receptors are outside the caveolae and some of the caveolae contain no receptors.</text></s></P><P><s sid="116"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>High magnification confocal images were collected and analyzed by ICCS to yield estimates of the density of receptor clusters, the density of caveolin clusters and the density of clusters that contain both receptor and caveolin (eqn. (7)).</text></s> <s sid="117"><CoreSc1 atype="GSC" type="Met" conceptID="Met1" novelty="New" advantage="None"/><text>The percent of caveolin-1 co-localizing with the BMP or EGF receptors was estimated using eqn. (8).</text></s> <s sid="118"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>Fig. 3B shows that prior to stimulation with BMP-2 the fraction of co-localization of caveolin-1 α, as detected with clone 2234, and BRIa is about 20% (one fifth of the caveolae contain the receptor) and that after stimulation, the fraction of co-localization is about 34% (one third of the caveolae contain the receptor).</text></s> <s sid="119"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs6" novelty="None" advantage="None"/><text>Stimulation by BMP-2 increases the co-localization by about 43% (<IT>p</IT> = 3.4 × 10<SP>−7</SP>).</text></s> <s sid="120"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs7" novelty="None" advantage="None"/><text>In contrast, the co-localzation of caveolin-1 α and β, detected with clone 2297 and BRIa is not significantly affected BMP-2 stimulation remaining at about 26–27% (<IT>p</IT> = 0.95).</text></s> <s sid="121"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>The combination of these observations, increase in co-localization with caveolin-1 α and no change with both, indicates that less caveolin-1 β co-localizes with BRIa following stimulation with BMP-2.</text></s> <s sid="122"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp2" novelty="None" advantage="None"/><text>The implication is that BMP-2 stimulation may form caveolae enriched in the caveolin-1 α isoform and BRIa.</text></s></P><P><s sid="123"><CoreSc1 atype="GSC" type="Res" conceptID="Res7" novelty="None" advantage="None"/><text>Fig. 3B also shows that BMP-2 stimulation does not significantly change the fraction of co-localization of caveolin-1 α and β with BRII, irrespective of which antibody is used to detect the caveolin-1 (clone 2297 or clone 2234) (<IT>p</IT> = 0.96 for clone 2234 and <IT>p</IT> = 0.98 for clone 2297).</text></s> <s sid="124"><CoreSc1 atype="GSC" type="Con" conceptID="Con4" novelty="None" advantage="None"/><text>This indicates that BRIa organization is more flexible than BRII on the cell surface..</text></s></P><P><s sid="125"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs8" novelty="None" advantage="None"/><text>Fig. 4B shows that EGF stimulation increases the co-localization of caveolin-1 α with ErbB1 by about 50% (<IT>p</IT> = 2.93 × 10<SP>−5</SP>).</text></s> <s sid="126"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs9" novelty="None" advantage="None"/><text>However, the co-localization of caveolin-1 α and β with ErbB1 is not changed significantly following EGF stimulation (<IT>p</IT> = 0.62).</text></s> <s sid="127"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>This observation is parallel to that observed for BRIa in Fig. 3B and the conclusion is equivalent: Stimulation of A431 cells by EGF causes the redistribution of caveolin-1 β into domains enriched in caveolin-1 α and the increase in caveolin-1 α co-localization with ErbB1 provides evidence for the existence of caveolae enriched in the caveolin-1 α isoform and ErbB1.</text></s></P></DIV><DIV DEPTH="2"><HEADER>Overexpression of caveolin-1 beta leads to an inhibition of BMP signaling</HEADER><P><s sid="128"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac20" novelty="None" advantage="None"/><text>Previous studies have shown that the interaction between the EGF receptor (ErbB1) and caveolin leads to inhibition of the kinase activity of the receptor.</text></s> <s sid="129"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp3" novelty="None" advantage="None"/><text>Since EGF stimulation causes a redistribution of caveolin-1 β it is possible that it is this isoform that specifically causes the inhibition and that the redistribution is intended to remove the inhibitory effect to allow signaling to take place.</text></s> <s sid="130"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp4" novelty="None" advantage="None"/><text>Since the BMP-2 and EGF stimulation cause the same effect, the first step is to determine whether there is inhibition of the BMP signaling when the interaction with the caveolin-1 β isoform is enhanced.</text></s> <s sid="131"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>Accordingly, we transfected the A431 cells with the caveolin-1 β isoform causing an overexpression.</text></s> <s sid="132"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>We then used a reporter gene assay to examine the influence of this overexpression on the activation of the Smad signaling pathway.</text></s> <s sid="133"><CoreSc1 atype="GSC" type="Exp" conceptID="Exp16" novelty="None" advantage="None"/><text>Specifically, we co-transfected pSBE (with a <IT>Renilla</IT> luciferase construct) into A431 cells since the pSBE is known to be responsive to the activation of BMP signaling.<REF TYPE="P" ID="cit43">43</REF></text></s> <s sid="134"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>As Fig. 5 shows, BMP-2 stimulation leads to a four-fold increase in luciferase activity in these starved cells.</text></s> <s sid="135"><CoreSc1 atype="GSC" type="Obs" conceptID="Obs10" novelty="None" advantage="None"/><text>However, co-expression of caveolin-1 β with the pSBE in A431 cells leads to a decrease in luciferase activity back to the level of unstimulated A431 cells even when they are stimulated with BMP-2.</text></s> <s sid="136"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>This suggests that the presence of excess caveolin-1 β isoform inhibits the BMP-2 signaling pathway.</text></s> <s sid="137"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>This is consistent with the previous studies on the ErbB1 that show that interaction of caveolin-1 with the EGF receptor inhibits receptor kinase activity, although in that work it was not attributed specifically to the caveolin-1 β isoform<REF TYPE="P" ID="cit44">44</REF>.</text></s></P></DIV></DIV><DIV DEPTH="1"><HEADER>Discussion</HEADER><P><s sid="138"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac2" novelty="None" advantage="None"/><text>Caveolin-1 can exist as two isoforms differing in their N-terminus.</text></s> <s sid="139"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac5" novelty="None" advantage="None"/><text>There is evidence that these isoforms play different roles in caveolae formation.<REF TYPE="P" ID="cit9">9</REF></text></s> <s sid="140"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac21" novelty="None" advantage="None"/><text>Caveolae enriched in caveolin-1 β are shallower than caveolae containing both caveolin-1 α and β.</text></s> <s sid="141"><CoreSc1 atype="GSC" type="Res" conceptID="Res1" novelty="None" advantage="None"/><text>In this work, we show that BMP and EGF receptors co-localize with these caveolin-1 isoforms in starved A431 cells to comparable extents.</text></s> <s sid="142"><CoreSc1 atype="GSC" type="Con" conceptID="Con1" novelty="None" advantage="None"/><text>Stimulation of these starved A431 cells with either BMP-2 or EGF leads to comparable redistributions of caveolae enriched in the caveolin-1 β isoform into caveolae containing both caveolin-1 α and β isoforms.</text></s> <s sid="143"><CoreSc1 atype="GSC" type="Res" conceptID="Res6" novelty="None" advantage="None"/><text>We are further able to show that the co-localization of BRIa with caveolae enriched in the caveolin-1 β isoform is decreased upon BMP-2 stimulation.</text></s> <s sid="144"><CoreSc1 atype="GSC" type="Res" conceptID="Res8" novelty="None" advantage="None"/><text>Similarly, we show that stimulation with EGF leads to an increase in the co-localization of caveolin-1 α with ErbB1, whereas the co-localization of caveolin-1 α and β with ErbB1 remains unchanged.</text></s> <s sid="145"><CoreSc1 atype="GSC" type="Res" conceptID="Res9" novelty="None" advantage="None"/><text>The cluster density of caveolin-1 α and β is decreased upon stimulation with BMP-2 or EGF, showing a redistribution of caveolin-1 β into domains enriched in caveolin-1 α.</text></s> <s sid="146"><CoreSc1 atype="GSC" type="Con" conceptID="Con5" novelty="None" advantage="None"/><text>This provided new evidence for the existence of caveolae enriched in the caveolin-1 α isoform only.</text></s> <s sid="147"><CoreSc1 atype="GSC" type="Con" conceptID="Con6" novelty="None" advantage="None"/><text>It is evident that the interaction of the receptors (BRIa and ErbB1) with the caveolin-1 isoforms is sensitive to the state of activation.</text></s> <s sid="148"><CoreSc1 atype="GSC" type="Con" conceptID="Con7" novelty="None" advantage="None"/><text>The fact that both BMP-2 and EGF induce the same redistribution of caveolin-1 suggests that the phenomenon may be general and that the redistribution is functionally important in the signaling process.</text></s></P><P><s sid="149"><CoreSc1 atype="GSC" type="Res" conceptID="Res2" novelty="None" advantage="None"/><text>We demonstrate that overexpression of the caveolin β isoform in starved A431 cells leads to an inhibition of BMP-2 induced signaling.</text></s> <s sid="150"><CoreSc1 atype="GSC" type="Con" conceptID="Con8" novelty="None" advantage="None"/><text>This provides evidence that the caveolin-1 β isoform may inhibit signaling in caveolae enriched in the caveolin-1 β, suggesting that these caveolae may function to sequester the receptors in non-functional domains until they are needed, that is, they may act as storage units for the receptors.</text></s> <s sid="151"><CoreSc1 atype="GSC" type="Res" conceptID="Res10" novelty="None" advantage="None"/><text>Upon stimulation, the receptors are released from the caveolin-1 β inhibitory effect as the caveolin-1 β redistributes.</text></s></P><P><s sid="152"><CoreSc1 atype="GSC" type="Bac" conceptID="Bac22" novelty="None" advantage="None"/><text>It is known that BMP receptors can form preformed complexes between BRIa and BRII prior to BMP-2 binding, but these preformed complexes do not signal in the absence of BMP-2.</text></s> <s sid="153"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/><text>Since BRII is a constitutively active kinase there must be a mechanism whereby the transphosphorylation of BRIa by BRII is silenced in the absence of BMP stimulation.</text></s> <s sid="154"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/><text>It is possible that the caveolin-1 β enriched domains serve this function.</text></s> <s sid="155"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/><text>In other words, the preformed complexes are inhibited by caveolin-1 β and the inhibition is released as a consequence of the redistribution of the caveolin-1 β in response to the BMP-2.</text></s> <s sid="156"><CoreSc1 atype="GSC" type="Hyp" conceptID="Hyp5" novelty="None" advantage="None"/><text>An analogous inhibitory effect may be exerted on the ErbB1 receptor.</text></s> <s sid="157"><CoreSc1 atype="GSC" type="Con" conceptID="Con9" novelty="None" advantage="None"/><text>Whatever the purpose, it is evident that there is an active and dynamic redistribution of caveolin-1 on the cell surface following BMP or EGF stimulation.</text></s> <s sid="158"><CoreSc1 atype="GSC" type="Con" conceptID="Con2" novelty="None" advantage="None"/><text>This demonstrates that caveolae are dynamic structures on the cell surface whose composition may change to influence the signaling activity.</text></s></P></DIV></BODY></PAPER>